Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Precursor T-Cell Lymphoblastic Leukemia-Lymphoma × Epirubicin × 90 days × Clear all

Sponsor

Conditions

Breast Neoplasms 4 Triple Negative Breast Neoplasms 3 Resectable HER2-positive Breast Cancer 1 Non-Muscle Invasive Bladder Neoplasms 1 Carcinoma, Adenoid Cystic 1

Interventions

Cyclophosphamide 9 Vincristine 7 venetoclax 5 prednylidene 5 deltacortene 5 Prednisone 5 Doxorubicin 5 merphos 4 dexamethasone acetate 4 dexamethasone 21-phosphate 4 auricularum 4 Methotrexate 4 Granulocyte Colony-Stimulating Factor 4 Filgrastim 4 Etoposide 4 Dexamethasone 4 Cytarabine 4 Calcium Dobesilate 4 pegaspargase 3 calaspargase pegol 3 Stem Cell Transplantation 3 Specimen Handling 3 Magnetic Resonance Spectroscopy 3 nelarabine 2 mogamulizumab 2 fludarabine phosphate 2 fludarabine 2 exifone 2 azathiopurine 2 Whole-Body Irradiation 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡